NYSE:ATNM

Actinium Pharmaceuticals Stock News

Healthcare > Biotechnology

Buy ATNM

*Your capital is at risk

$1.11

-0.0500 (-4.31%)

At Close: Jun 04, 2026

Shareholders Are Encouraged To Join The Schall Law Firm's Inquiry In Actinium Pharmaceuticals, Inc. For Securities Law Violations

11:00am, Friday, 13'th Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 13, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Actinium Pha

The Schall Law Firm Is Looking Into Whether Actinium Pharmaceuticals Inc Committed Securities Fraud And Investors With Losses Can Reach Out

11:00am, Thursday, 12'th Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Actinium Pha

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Actinium Pharmaceuticals, Inc. - ATNM

05:45pm, Wednesday, 11'th Sep 2024

NEW YORK, NY / ACCESSWIRE / September 11, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Actinium Pharmaceuticals, Inc. ("Actinium" or the "Company") (NYSE:ATNM). Such investor

Stakeholders In Actinium Pharmaceuticals Inc. Are Encouraged To Contribute To The Schall Law Firm's Inquiry

11:00am, Wednesday, 11'th Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Actinium Pha

IBA's joint venture PanTera secures EUR 93 million in oversubscribed Series A round to accelerate global actinium-225 production

01:00am, Wednesday, 11'th Sep 2024

Louvain-la-Neuve, Belgium, September 11, 2024 – IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, is pleased to share the below press release from its joint vent

Actinium Pharmaceuticals Inc May Have Violated Securities Regulations And The Schall Law Firm Invites Investors To Help With An Investigation

11:00am, Tuesday, 10'th Sep 2024

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Actinium Pharmaceuticals, Inc. ("Actinium" or "the Company") (NY

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Actinium Pharmaceuticals, Inc. - ATNM

10:16pm, Monday, 09'th Sep 2024

NEW YORK , Sept. 9, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Actinium Pharmaceuticals, Inc. ("Actinium" or the "Company") (NYSE: ATNM).

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Actinium Pharmaceuticals, Inc. - ATNM

12:00pm, Saturday, 07'th Sep 2024

NEW YORK, NY / ACCESSWIRE / September 7, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Actinium Pharmaceuticals, Inc. ("Actinium" or the "Company") (NYSE:ATNM). Such investors

Securities Laws May Have Been Violated By Actinium Pharmaceuticals Inc And The Schall Law Firm Invites Investors To Join An Investigation

11:00am, Saturday, 07'th Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Actinium Phar

Actinium Pharmaceuticals, Inc. Might Have Committed Securities Fraud And Impacted Stockholders Can Partake In The Schall Law Firm's Inquiry

11:00am, Friday, 06'th Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Actinium Phar

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Actinium Pharmaceuticals, Inc. - ATNM

05:00pm, Thursday, 05'th Sep 2024

NEW YORK, NY / ACCESSWIRE / September 5, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Actinium Pharmaceuticals, Inc. ("Actinium" or the "Company") (NYSE:ATNM). Such investors

Investors are Invited To Join The Schall Law Firm In An Investigation Into Actinium Pharmaceuticals Inc's Potential Securities Related Infractions

11:00am, Thursday, 05'th Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Actinium Phar

Actinium Pharmaceuticals Inc. Is Being Looked Into By The Schall Law Firm For Violating Securities Related Laws And Shareholders Should Reach Out

11:00am, Wednesday, 04'th Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Actinium Phar

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Actinium Pharmaceuticals, Inc. - ATNM

08:31pm, Tuesday, 03'rd Sep 2024

NEW YORK , Sept. 3, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Actinium Pharmaceuticals, Inc. ("Actinium" or the "Company") (NYSE: ATNM).

Investors With Losses In Actinium Pharmaceuticals Inc Are Urged To Contact The Schall Law Firm About A Securities Fraud Inquiry

11:00am, Tuesday, 03'rd Sep 2024

LOS ANGELES, CA / ACCESSWIRE / September 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Actinium Phar

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by